Omicron risk remains very high: WHO
Omicron continues to increase its dominance globally over the other variants of concern
GENEVA: The risk level related to the Omicron variant remains very high, the WHO said late Tuesday, with the numbers of new COVID-19 cases hitting another record high last week.
"Over 21 million new cases were reported, representing the highest number of weekly cases recorded since the beginning of the pandemic," the World Health Organization said in its weekly epidemiological coronavirus update.
The UN health agency said the number of new infections increased by 5% in the week to Sunday -- compared to the 20% rise registered the week before.
"A slower increase in case incidence was observed at the global level," the WHO said.
Nearly 50,000 new deaths were also reported, it added -- a similar figure to the week before.
The report said Omicron continued to increase its dominance globally over the other variants of concern.
"The current global epidemiology of SARS-CoV-2 is characterised by the dominance of the Omicron variant on a global scale, continued decline in the prevalence of the Delta variant, and very low-level circulation of Alpha, Beta and Gamma variants," the WHO said.
"Countries that experienced a rapid rise in Omicron cases in November and December 2021 have been or are beginning to see declines in cases.
However, "based on the currently available evidence, the overall risk related to the Omicron variant remains very high".
The WHO said that of samples collected in the last 30 days that have been sequenced and uploaded to the GISAID global science initiative, Omicron accounted for 89.1%.
Delta -- previously the world's dominant variant -- now makes up 10.7%.
-
Antioxidants found to be protective agents against cognitive decline
-
Coffee reduces cancer risk, research suggests
-
Keto diet emerges as key to Alzheimer's cure
-
What you need to know about ischemic stroke
-
Shocking reason behind type 2 diabetes revealed by scientists
-
Simple 'finger test' unveils lung cancer diagnosis
-
Groundbreaking treatment for sepsis emerges in new study
-
All you need to know guide to rosacea